key: cord-0909332-gejm5akv authors: Dey, Debajit; Borkotoky, Subhomoi; Banerjee, Manidipa title: In silico identification of Tretinoin as a SARS-CoV-2 Envelope (E) protein ion channel inhibitor date: 2020-10-20 journal: Comput Biol Med DOI: 10.1016/j.compbiomed.2020.104063 sha: 62b5b23dc91e9b699a5add60b4f9ad62d385de04 doc_id: 909332 cord_uid: gejm5akv Viroporins are oligomeric, pore forming, viral proteins that play critical roles in the life cycle of pathogenic viruses. Viroporins like HIV-1 Vpu, Alphavirus 6K, Influenza M2, HCV p7, and Picornavirus 2B, form discrete aqueous passageways which mediate ion and small molecule transport in infected cells. The alterations in host membrane structures induced by viroporins is essential for key steps in the virus life cycle like entry, replication and egress. Any disruption in viroporin functionality severely compromises viral pathogenesis. The envelope (E) protein encoded by coronaviruses is a viroporin with ion channel activity and has been shown to be crucial for the assembly and pathophysiology of coronaviruses. We used a combination of virtual database screening, molecular docking, all-atom molecular dynamics simulation and MM-PBSA analysis to test four FDA approved drugs - Tretinoin, Mefenamic Acid, Ondansetron and Artemether - as potential inhibitors of ion channels formed by SARS-CoV-2 E protein. Interaction and binding energy analysis showed that electrostatic interactions and polar solvation energy were the major driving forces for binding of the drugs, with Tretinoin being the most promising inhibitor. Tretinoin bound within the the lumen of the channel formed by E protein, which is lined by hydrophobic residues like Phe, Val and Ala, indicating its potential for blocking the channel and inhibiting the viroporin functionality of E. In control simulations, tretinoin demonstrated a lower binding energy with a known target as compared to SARS-CoV-2 E protein. This work thus highlights the possibility of exploring Tretinoin as a potential SARS-CoV-2 E protein ion channel blocker and virus assembly inhibitor, which could be an important therapeutic strategy in the treatment for coronaviruses. . A synthetic version of the TMD assembles into pentamers that form 68 cation-selective membrane pores. The ion channels generated by E of SARS-CoV in ERGIC 69 membranes transports Ca 2+ , which was shown to activate the NLRP3 inflammasome 70 activation, and IL-1βoverproduction(Nieto- Torres However, the mechanistic link between the ion channel activity of E, and its membrane 78 bending functionality that facilitates virus budding, is not clearly understood. 79 The E protein of coronaviruses contains several motifs, apart from the TMD, that are 80 necessary for its functionality. Aβ-coil-β-motif, containing a highly conserved proline 81 residue, is necessary for the targeting of the protein to the golgi complex. Mutation of this 82 residue retargets E to the plasma membrane, which inhibits the assembly and release of CoV Alanine, Valine, Phenylalanine and Leucine [ Figure 1C ]. The N and C termini were 244 hydrophilic, as expected [ Figure 1A ]. Both the hydrophobicity profile and the sequence of E 245 were found to be highly conserved between SARS-CoV and SARS-CoV-2 [ Figure 1A , 1D]. 246 The SARS CoV E protein structure was earlier solved by solution NMR (Pervushin et al. Viral proteins function as ion channels The effect of amantadine on an ion channel protein from Chikungunya virus Protein-protein interactions of viroporins in 444 coronaviruses and paramyxoviruses: New targets for antivirals? Viruses7 Coronavirus envelope protein: Current knowledge Structural and Functional Aspects of Viroporins in Human Respiratory Viruses: Respiratory Syncytial Virus and Coronaviruses Respiratory Disease and Infection -A New Insight The M, E, and N Structural Proteins of the Severe Acute Respiratory 456 Syndrome Coronavirus Are Required for Efficient Assembly, Trafficking, and Release of Virus-Like Particles A Severe Acute Respiratory Syndrome Coronavirus That Lacks the E Gene Is Attenuated In Vitro and In Vivo Identification of a Golgi Complex-Targeting 461 Signal in the Cytoplasmic Tail of the Severe Acute Respiratory Syndrome Coronavirus 462 Emerging Theme: Cellular PDZ Proteins as Common Targets 464 of Pathogenic Viruses The PDZ-Binding Motif of Severe Acute Respiratory Syndrome Coronavirus Envelope Protein Is a Determinant of Viral Pathogenesis The SARS coronavirus E protein interacts with PALS1 and alters tight 469 junction formation and epithelial morphogenesis Structure of the amantadine binding site of influenza M2 proton 471 channels in lipid bilayers Where does amantadine bind to the 473 influenza virus M2 proton channel? I-TASSER server for protein 3D structure prediction Protein Structure and Function Prediction Using I-TASSER Protein structure refinement driven by side-479 chain repacking GalaxyHomomer: A web server for 481 protein homo-oligomer structure prediction from a monomer sequence or structure. docking Optimized GPU implementation of Merck 488 Molecular Force Field and Universal Force Field AutoDock Vina: Improving the speed and 24. Molecules, O. a Universal Force Field. Molecules Steepest Descent Method. in 493 Introduction to Unconstrained Optimization with R The Origin of the Method of Steepest Descent Avogadro: An advanced semantic chemical editor, visualization, and 498 analysis platform PRODIGY: A 500 web server for predicting the binding affinity of protein PLIP: Fully 503 automated protein-ligand interaction profiler Pymol: An open-source molecular graphics tool. CCP4 Newsl. Protein Mechanism of Action, Antiviral drug promises and rule out against its treatment Identification of chymotrypsin-556 like protease inhibitors of SARS-CoV-2 via integrated computational approach Discovery of Potential Multi-Target-Directed Ligands by Targeting 559 Host-specific SARS-CoV-2 Structurally Conserved Main Protease Andrographolide As a Potential 562 Inhibitor of SARS-CoV-2 Main Protease: An In Silico Approach Moroccan Medicinal plants as inhibitors of COVID-19: Computational 565 investigations Drug repurposing for 567 coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL 568 hydrolase and protease enzymes A computational prediction of SARS-CoV-2 587 structural protein inhibitors from Azadirachta indica (Neem)